Jena Patel
Papers
1
Total Citations
13
H-Index
1
About
Dr. Jena Patel is a surgical oncologist whose research focuses on the intersection of immunotherapy and head and neck cancer surgery, with a particular emphasis on optimizing perioperative outcomes. Her most cited work, "Effect of preoperative programmed death‐1 or programmed death ligand‐1 immune check point inhibition on complications after surgery for primary head and neck cancer" (2023, 13 citations), addresses a critical gap in the literature by systematically comparing complication rates between patients receiving neoadjuvant immune checkpoint inhibitors and those undergoing surgery alone for head and neck squamous cell carcinoma (HNSCC). This pioneering study provides essential safety data for a rapidly evolving treatment paradigm, helping to guide clinical decision-making in an area where evidence was previously sparse. Dr. Patel's contributions are particularly valuable as immunotherapy becomes increasingly integrated into head and neck cancer treatment protocols. Her work demonstrates a commitment to evidence-based surgical oncology, ensuring that innovative therapies are implemented with a thorough understanding of their impact on surgical outcomes. For students and researchers, Dr. Patel's research exemplifies the importance of evaluating new therapeutic combinations through rigorous clinical investigation.
Research Focus
Key Achievements
Top Papers
- 1